Samia Q. Khan, et al. EDIT-202, a Multiplexed CRISPR-Cas12a Gene-Edited iPSC-Derived NK Cell Therapy, has Prolonged Persistence, Promotes High Cytotoxicity, and Enhances In Vivo Tumor Killing. Presented at The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, May 16-19, 2022.

Warning: file_get_contents(http://ir.editasmedicine.com/rss/news-releases.xml): Failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /tmp/sage-cache/d48bd814cd468bf3628e57525893768a084254de.php on line 27

Warning: Attempt to read property "channel" on bool in /tmp/sage-cache/d48bd814cd468bf3628e57525893768a084254de.php on line 35

Warning: Attempt to read property "item" on null in /tmp/sage-cache/d48bd814cd468bf3628e57525893768a084254de.php on line 35

Warning: foreach() argument must be of type array|object, null given in /tmp/sage-cache/d48bd814cd468bf3628e57525893768a084254de.php on line 35